Nautilus Biotechnolgy Inc. (NASDAQ: NAUT)
$2.70
+0.0900 ( +3.45% ) 115.6K
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
Market Data
Open
$2.70
Previous close
$2.61
Volume
115.6K
Market cap
$341.97M
Day range
$2.61 - $2.74
52 week range
$2.19 - $4.00
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 8-k | 8K-related | 15 | Feb 28, 2024 |
| 8-k | 8K-related | 15 | Feb 28, 2024 |
| 10-k | Annual reports | 94 | Feb 28, 2024 |
| 8-k | 8K-related | 12 | Dec 14, 2023 |
| 8-k | 8K-related | 13 | Oct 31, 2023 |
| 10-q | Quarterly Reports | 60 | Oct 31, 2023 |
| 10-q | Quarterly Reports | 77 | Aug 02, 2023 |